Medical Health Cluster

neurological

New Guidance on Neurological Complications of Long-COVID

The American Academy of Physical Medicine and Rehabilitation (AAPM&R) has issued new consensus guidance on the assessment and treatment of neurologic sequelae in patients with long COVID, also known as post-acute sequelae of SARS-CoV-2 infection (PASC). The new recommendations, which were published online May 16 in Physical Medicine & Rehabilitation, […]

Read More

No Increased Risk of Rare Neurological Events After COVID Vaccination

A new study finds no increased risk of rare neurological events after COVID-19 vaccination, but does find an increased risk of these events after SARS-CoV-2 infection. The European Medicines Agency (EMA) listed Guillain-Barré syndrome as a rare side effect of the Oxford-AstraZeneca and Pfizer-BioNTech COVID vaccines following reports that some […]

Read More

Respiratory, Cardiac, and Neurological Red Flags for Long COVID

Watch for the big three red flags – cardiac (ischaemia, tachyarrhythmia, myocarditis and pericarditis), neurological (TIA and stroke) and respiratory (pulmonary embolism) in patients with long COVID, says the GP lead of one of the country’s first long COVID clinics. Dr Harsha Master, lead in COVID assessment and rehabilitation, Hertfordshire Community NHS […]

Read More

Autoantibodies Might Affect Acute Disease Severity and Neurological Symptoms

Concentrations of autoantibodies correlate with disease severity. Why do some people get so much sicker than others with acute COVID-19? And what causes the neurological symptoms — anosmia, fatigue, encephalopathy — seen in some patients? A team from Yale employed a new technology for finding autoantibodies to 2770 extracellular and […]

Read More

Autoantibodies Might Affect Acute Disease Severity and Neurological Symptoms

Concentrations of autoantibodies correlate with disease severity. Why do some people get so much sicker than others with acute COVID-19? And what causes the neurological symptoms — anosmia, fatigue, encephalopathy — seen in some patients? A team from Yale employed a new technology for finding autoantibodies to 2770 extracellular and […]

Read More

6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records

Summary Background Neurological and psychiatric sequelae of COVID-19 have been reported, but more data are needed to adequately assess the effects of COVID-19 on brain health. We aimed to provide robust estimates of incidence rates and relative risks of neurological and psychiatric diagnoses in patients in the 6 months following […]

Read More